Perspective
Our work in Perspective
-
Responses to Congressional Request for Information about Cannabidiol from US Congress
Schaeffer experts submitted a comment letter responding to a recent request for information (RFI) related to cannabidiol.
Categorized in -
Blame Capitalism? Why Hundreds of Decades-Old Yet Vital Drugs Are Nearly Impossible to Find
The shortages, which have been going on for years, have typically affected only low-cost generics rather than profitable brand-name drugs.
Categorized in -
Centers for Disease Control and Prevention Guideline for Prescribing Opioids, 2022—Need for Integrating Dosing Benchmarks with Shared Decision-Making
A fully individualized, unstructured decision-making process
will not be adequate to protect patients receiving long-term opioid
therapy.Categorized in -
Congress Can Eradicate Hepatitis C and Reduce the Deficit at the Same Time
The initiative comes with a $12.3 billion price tag — and over 10 years, the savings in health care costs will reach $18.1 billion.
Categorized in -
Lowering Medicare Advantage Overpayments from Favorable Selection by Reforming Risk Adjustment
One potential path for reducing Medicare Advantage (MA) overpayments from favorable selection is reforming the current administered payment approaches linking spending in fee-for-service (FFS) to MA rates.
Categorized in -
Why Doctors Using ChatGPT Are Unknowingly Violating HIPAA
USC Schaeffer Center senior fellow Genevieve Kanter says the risk to patient privacy posed by AI chatbots presents unique challenges.
Categorized in -
Health Care Privacy Risks of AI Chatbots
Ultimately, health systems facing increased risk of AI chatbot breaches must decide whether to discourage clinicians’ use of this technology or embrace it.
Categorized in -
Without Early Detection, Fighting Dementia Is an Uphill Battle
A brief assessment in primary care can help identify patients most at risk
Categorized in -
Blood Pressure Medication and Dementia Prevention: The Promising Link
SC Schaeffer Center researchers have turned to real-world data to probe the relationship between antihypertensive use and dementia risk in the U.S. population and among minoritized populations who are at the highest risk of dementia.
Categorized in -
Favorable Selection Ups the Ante on Medicare Advantage Payment Reform
Overpayment to Medicare Advantage plans due to favorable selection, “coding intensity” and rating bonuses could exceed $75B in 2023.
Categorized in